AK Medical Holdings Limited (AK Medical) disclosed that it repurchased 20,000 ordinary shares on 6 October 2026 via on-market transactions at HK$4.75 per share, for a total consideration of HK$95,000.

Following the buyback: • Issued shares outstanding (excluding treasury stock) declined to 1.07697 billion, representing a marginal 0.0019% reduction versus the previous day’s balance. • Treasury shares increased to 33.01 million, keeping total issued share capital unchanged at 1.10998 billion shares.

Repurchase mandate utilisation: • The board-approved mandate dated 17 June 2026 authorises repurchases of up to 112.46 million shares. • Cumulative repurchases now stand at 48.58 million shares, equal to 4.32% of the company’s issued share base on the mandate date. • Approximately 63.89 million shares remain available for buyback under the existing authority.

Regulatory window: • In line with Hong Kong Listing Rules, AK Medical is restricted from issuing new shares or selling treasury stock until 5 November 2026 (30 days after the latest repurchase).

All repurchases were executed in compliance with the Hong Kong Stock Exchange’s Main Board Rules, and the repurchased shares are being held in treasury pending any future cancellation or other corporate actions.